Dr. Krishnaveni Sirigaddi, MD

Dr. Sirigaddi practices at UMass Memorial Health - Harrington Hospital in Southbridge, Massachusetts, part of UMass Memorial Health Care.

Dr. Sirigaddi's NPI, 1013545326, was assigned on March 31, 2020. Dr. Sirigaddi holds Massachusetts license 1014059.

Dr. Sirigaddi's primary practice is UMass Memorial Health - Harrington Hospital, at 100 South Street, Southbridge, MA 01550 in Worcester County. The practice phone is (508) 765-9771.

Dr. Sirigaddi's primary practice is UMass Memorial Health - Harrington Hospital in Southbridge, Massachusetts, part of UMass Memorial Health Care. Dr. Sirigaddi is also affiliated with Saint Vincent Hospital. The medical group on file is UMass Memorial Medical Group. Dmand AI also links Dr. Sirigaddi to 1 more hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sirigaddi practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sirigaddi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sirigaddi is licensed in Massachusetts.

CMS data shows 671 Medicare services from Dr. Sirigaddi across 6 procedure codes in 2024, for 233 Medicare patients. Medicare paid $61,472 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 233 Medicare patients who saw Dr. Sirigaddi in 2024. The largest group is 75 to 84, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sirigaddi's median patient age at 76, with 45% women.

In 2024, Dr. Sirigaddi wrote 348 Medicare Part D claims for 153 patients. 86% of them were for generic drugs. CMS names the drug for 107 of them, across 6 drugs with 11 or more claims each, at $1,243 in total drug cost. In 2023, CMS named 156 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Sirigaddi for performance year 2024, reported through an alternative payment model (APM). Dr. Sirigaddi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Sirigaddi, published from 2018 to 2024. The most frequent topics are Anemia, Sickle Cell. Dr. Sirigaddi's most frequent co-authors are Nibras F. Bughrara, MD, Smita Bhatia, MD and Lee M. Hilliard, MD.

CMS Open Payments shows 3 general payments to Dr. Sirigaddi from 3 drug and device companies in 2023. Food and beverage make up the largest share, 100% of the total. Alexion Pharmaceuticals, Inc. paid the most, $24.